Ambagon Therapeutics
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
953 Indiana St, San Francisco, Californi...Phone Number
(415) 235-6373Website
www.ambagontx.comRevenue
$6.8 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
1
1
1
1
1
About Ambagon Therapeutics
Ambagon Therapeutics is a biotechnology company pioneering methods to unlock intrinsically disordered protein targets using small molecules.Explore more
Ambagon Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Ambagon Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Ambagon Therapeutics launches new products
Congratulate Masked Content for being promoted to Masked Content at Ambagon Therapeutics
Ambagon Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Ambagon Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on Ambagon Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Ambagon Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Ambagon Therapeutics is spiking on competitors!
Funding: Get notified immidiatlly once Ambagon Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Ambagon Therapeutics
Compare insights from companies similar to Ambagon Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Ambagon Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Ambagon Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Ambagon Therapeutics.
Ambagon Therapeutics financials insights
Gather financial insights about Ambagon Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Series A
$85M
Ambagon Therapeutics Tech Stack
A closer look at the technologies used by Ambagon Therapeutics
Most Recent Scoops
Person-Based
Medical Research, Pharmaceuticals
Event
Events
New Hire
Executive Move
Thomas Marty has joined the organization as Vice President, Finance.
Executive Moves, New Hire
Funding
Funding
Funding
Ambagon Therapeutics News & Media
Ambagon Therapeutics wordt gelanceerd met $ 85 miljoen Serie A om baanbrekend moleculair lijmplatform en voortgangspijplijn te bevorderen
SAN FRANCISCO--(BUSINESS WIRE)--Ambagon Therapeutics, een biotechnologiebedrijf dat intrinsiek ongeordende eiwitten en andere moeilijk te targeten eiwitklassen ontsluit, heeft vandaag een Serie A ter waarde van $ 85 miljoen aangekondigd om zijn platform voor medicijnontdekking te vergroten en zijn pijplijn van moleculaire lijmen vooruit te helpen. De financiering werd geleid door Nextech Invest. Ambagon was eerder opgezet door RA Capital Management, Droia Ventures, Inkef Capital, AbbVie VentureNew Biotech Earns $85 Million in Series A Funding | BioSpace
Ambagon Therapeutics closes its first financing round with $85 million. The Series A funds will help advance the company's drug discovery platform and molecular glue pipeline.Ambagon: TU Eindhoven spin-off raises 75 million euros to develop new cancer treatments ...
The biotechnology start-up Ambagon Therapeutics has raised 75 million euros (85 million dollars) in a financing round. With the money, theAmbagon Therapeutics Launches With $85 Million Series A to Advance Pioneering ... - Dutch News
Ambagon Therapeutics Launches With $85 Million Series A to Advance Pioneering Molecular Glue Platform and Progress Pipeline
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ambagon Therapeutics
Sign Up For FreeTo access detailed company insights
Ambagon Therapeutics is a biotechnology company pioneering methods to unlock intrinsically disordered protein targets using small molecules.... Read More
